Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0089
-0.0001 (-1.11%)
At close: Mar 6, 2026
Evofem Biosciences Employees
Evofem Biosciences had 32 employees as of December 31, 2024. The number of employees decreased by 6 or -15.79% compared to the previous year.
Employees
32
Change (1Y)
-6
Growth (1Y)
-15.79%
Revenue / Employee
$553,938
Profits / Employee
-$173,594
Market Cap
1.13M
Employees Chart
Evofem Biosciences News
- 6 weeks ago - Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women's Health at Fierce JPM Week 2026 - Business Wire
- 6 weeks ago - Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store - Business Wire
- 3 months ago - Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE - PRNewsWire
- 4 months ago - Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update - PRNewsWire
- 4 months ago - Evofem Announces Voting Results from Special Meeting of Stockholders - PRNewsWire
- 5 months ago - Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates - PRNewsWire
- 5 months ago - Evofem Biosciences Honors World Contraception Day - PRNewsWire
- 6 months ago - Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms - PRNewsWire